358 related articles for article (PubMed ID: 15289381)
1. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.
Kim YK; Suarez J; Hu Y; McDonough PM; Boer C; Dix DJ; Dillmann WH
Circulation; 2006 Jun; 113(22):2589-97. PubMed ID: 16735677
[TBL] [Abstract][Full Text] [Related]
3. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.
Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA
Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
[TBL] [Abstract][Full Text] [Related]
6. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.
Zhang S; Weinheimer C; Courtois M; Kovacs A; Zhang CE; Cheng AM; Wang Y; Muslin AJ
J Clin Invest; 2003 Mar; 111(6):833-41. PubMed ID: 12639989
[TBL] [Abstract][Full Text] [Related]
7. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
[TBL] [Abstract][Full Text] [Related]
8. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
[TBL] [Abstract][Full Text] [Related]
9. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
Liu Q; Sargent MA; York AJ; Molkentin JD
Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
[TBL] [Abstract][Full Text] [Related]
10. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
11. Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival.
Zhang S; Ren J; Zhang CE; Treskov I; Wang Y; Muslin AJ
Circ Res; 2003 Nov; 93(11):1026-8. PubMed ID: 14593000
[TBL] [Abstract][Full Text] [Related]
12. Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy.
Mutlak M; Schlesinger-Laufer M; Haas T; Shofti R; Ballan N; Lewis YE; Zuler M; Zohar Y; Caspi LH; Kehat I
Int J Cardiol; 2018 Nov; 270():204-213. PubMed ID: 29857938
[TBL] [Abstract][Full Text] [Related]
13. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.
Ruppert C; Deiss K; Herrmann S; Vidal M; Oezkur M; Gorski A; Weidemann F; Lohse MJ; Lorenz K
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7440-5. PubMed ID: 23589880
[TBL] [Abstract][Full Text] [Related]
14. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38α mitogen-activated protein kinase mice.
Sari FR; Widyantoro B; Thandavarayan RA; Harima M; Lakshmanan AP; Zhang S; Muslin AJ; Suzuki K; Kodama M; Watanabe K
Cell Physiol Biochem; 2011; 27(5):487-96. PubMed ID: 21691066
[TBL] [Abstract][Full Text] [Related]
16. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
[TBL] [Abstract][Full Text] [Related]
17. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.
Rapacciuolo A; Esposito G; Caron K; Mao L; Thomas SA; Rockman HA
J Am Coll Cardiol; 2001 Sep; 38(3):876-82. PubMed ID: 11527648
[TBL] [Abstract][Full Text] [Related]
18. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
19. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
20. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
